MicroRNAs: Following a single 4-hour HP treatment, decreases were observed in seven out of ten miRNAs examined in two of the three participants. MicroRNAs are one component of the cargo of ...

said James (Jim) Frakes, CEO and CFO of Aethlon Medical. In the initial three patients, there were encouraging changes in ...

Recent clinical trial update news from Aethlon Medical, Inc. (NASDAQ: AEMD), Envoy Medical, Inc. (NASDAQ: COCH), Soligenix, ...

A new review highlights sepsis-induced immunosuppression as a key driver of mortality, summarizing current research and ...

ImmunityBio, Inc. (NASDAQ:IBRX) is one of the Best Penny Stocks to Buy with the Highest Upside Potential. On September 8, ...

Risk factors for CMV infection among adults with RMDs included diabetes, prior malignancy, IV cyclophosphamide, and initial prednisolone >0.91 mg/kg/day.

Indonesia’s Health Ministry confirmed that nine people who tested positive during a whole-body counter (WBC) examination for ...

Primary overall survival analysis from the Phase 3 monarchE study of Verzenio (abemaciclib) in HR+HER2-, node-positive, high-risk early breast cancer to ...

Investorideas.com, a go-to investing platform covering biotech and medtech stocks releases an industry snapshot looking ...

Poor sleep may age your brain by nearly a year, new research shows. Five key sleep habits could help protect brain health and ...

Recent clinical trial update news from Aethlon Medical, Inc. ( Nasdaq: AEMD ), Envoy Medical, Inc. ( Nasdaq: COCH ), ...

ImmunityBio offers significant upside despite ongoing dilution and cash burn concerns. Click here to read an analysis of IBRX ...